HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Non-pathogenic Recombinant Leishmania Expressing Lipophosphoglycan 3 Against Experimental Infection with Leishmania infantum.

Abstract
Visceral leishmaniasis (VL) is caused by Leishmania infantum in the Mediterranean basin and affects primarily children and immunosuppressed individuals. Various strategies of vaccination have so far been examined by either protein or DNA without achievable complete protection against the disease. The live non-pathogenic lizard parasite, Leishmania tarentolae, expressing elected Leishmania antigens has recently provided a promising new approach as a safe and effective live vaccine candidate to prevent leishmaniasis. Here, we evaluated the immunoprotective potential of a live recombinant L. tarentolae expressing Lipophosphoglycan 3 (LPG3) antigen against L. infantum infection in BALB/c mice. Results indicated that the administration of live recombinant Leishmania produced a significant high level of IFN-γ accompanied by reduced levels of IL-10 as compared to wild-type parasites as live vaccine control, thus suggesting the induction of a Th1-type immune response in a mouse model of visceral leishmaniasis. Analysis of the IgG antibody response also showed high levels of IgG2a relative to IgG1 in sera of mice immunized with recombinant Leishmania parasites. However, immune responses elicited by this live vaccine conferred partial protection against infectious challenge. Therefore, further studies are required to increase its protective efficacy.
AuthorsL Pirdel, S Farajnia
JournalScandinavian journal of immunology (Scand J Immunol) Vol. 86 Issue 1 Pg. 15-22 (Jul 2017) ISSN: 1365-3083 [Electronic] England
PMID28426153 (Publication Type: Journal Article)
Copyright© 2017 The Foundation for the Scandinavian Journal of Immunology.
Chemical References
  • Antibodies, Protozoan
  • Immunoglobulin G
  • Leishmaniasis Vaccines
  • Protozoan Proteins
  • Recombinant Proteins
  • Interleukin-10
  • Interferon-gamma
Topics
  • Animals
  • Antibodies, Protozoan (blood, immunology)
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Immunoglobulin G (blood, immunology)
  • Interferon-gamma (immunology, metabolism)
  • Interleukin-10 (immunology, metabolism)
  • Leishmania infantum (immunology, physiology)
  • Leishmaniasis Vaccines (administration & dosage, immunology)
  • Leishmaniasis, Visceral (immunology, parasitology, prevention & control)
  • Mice, Inbred BALB C
  • Protozoan Proteins (administration & dosage, genetics, immunology)
  • Recombinant Proteins (administration & dosage, immunology)
  • Spleen (drug effects, immunology, parasitology)
  • Treatment Outcome
  • Vaccination (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: